16-11896611-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000434724.7(GSPT1):c.611C>T(p.Pro204Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,609,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000434724.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSPT1 | NM_002094.4 | c.611C>T | p.Pro204Leu | missense_variant | 4/15 | ENST00000434724.7 | NP_002085.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSPT1 | ENST00000434724.7 | c.611C>T | p.Pro204Leu | missense_variant | 4/15 | 1 | NM_002094.4 | ENSP00000398131 | ||
RSL1D1-DT | ENST00000574364.2 | n.589+1000G>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 241970Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 130998
GnomAD4 exome AF: 0.00000961 AC: 14AN: 1457122Hom.: 0 Cov.: 31 AF XY: 0.00000552 AC XY: 4AN XY: 724258
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.611C>T (p.P204L) alteration is located in exon 4 (coding exon 4) of the GSPT1 gene. This alteration results from a C to T substitution at nucleotide position 611, causing the proline (P) at amino acid position 204 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at